Free Trial

MarketBeat Instant News Alerts

AstraZeneca logo with Medical background

AstraZeneca (LON:AZN) Given Sell Rating at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reissued a "sell" rating and set a £115 price target on shares of AstraZeneca in a report on Wednesday.

LON:AZN
Read AstraZeneca (LON:AZN) Given Sell Rating at Deutsche Bank Aktiengesellschaft
GSK logo with Medical background

GSK (LON:GSK) Receives Hold Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 1,900 price target on shares of GSK in a research note on Wednesday.

LON:GSK
Read GSK (LON:GSK) Receives Hold Rating from Deutsche Bank Aktiengesellschaft
HSBC logo with Financial Services background

HSBC Reaffirms "Hold" Rating for HSBC (LON:HSBA)

HSBC reiterated a "hold" rating and issued a GBX 1,450 target price on shares of HSBC in a research report on Wednesday.

LON:HSBA
Read HSBC Reaffirms "Hold" Rating for HSBC (LON:HSBA)
Unilever logo with Consumer Defensive background

Unilever (LON:ULVR) Receives "Hold" Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a GBX 5,150 target price on shares of Unilever in a report on Wednesday.

LON:ULVR
Read Unilever (LON:ULVR) Receives "Hold" Rating from Deutsche Bank Aktiengesellschaft
Whitbread logo with Consumer Cyclical background

Deutsche Bank Aktiengesellschaft Issues Pessimistic Forecast for Whitbread (LON:WTB) Stock Price

Deutsche Bank Aktiengesellschaft cut their price target on shares of Whitbread from GBX 2,815 to GBX 2,530 and set a "hold" rating for the company in a report on Wednesday.

LON:WTB
Read Deutsche Bank Aktiengesellschaft Issues Pessimistic Forecast for Whitbread (LON:WTB) Stock Price
J D Wetherspoon logo with Consumer Cyclical background

J D Wetherspoon (LON:JDW) Earns Buy Rating from Jefferies Financial Group

Jefferies Financial Group reiterated a "buy" rating and issued a GBX 840 price objective on shares of J D Wetherspoon in a report on Wednesday.

LON:JDW
Read J D Wetherspoon (LON:JDW) Earns Buy Rating from Jefferies Financial Group

Trending News

All MarketBeat Instant News Alerts

NEXT logo with Consumer Cyclical background

NEXT's (NXT) Buy Rating Reiterated at Shore Capital Group

LON:NXT
Read NEXT's (NXT) Buy Rating Reiterated at Shore Capital Group
Vanquis Banking Group logo with Financial Services background

Vanquis Banking Group (LON:VANQ) Receives "Buy" Rating from Shore Capital Group

LON:VANQ
Read Vanquis Banking Group (LON:VANQ) Receives "Buy" Rating from Shore Capital Group
JD Sports Fashion logo with Consumer Cyclical background

Shore Capital Group Reiterates "Hold" Rating for JD Sports Fashion (LON:JD)

LON:JD
Read Shore Capital Group Reiterates "Hold" Rating for JD Sports Fashion (LON:JD)
Telecom Plus logo with Utilities background

Deutsche Bank Aktiengesellschaft Reaffirms "Hold" Rating for Telecom Plus (LON:TEP)

LON:TEP
Read Deutsche Bank Aktiengesellschaft Reaffirms "Hold" Rating for Telecom Plus (LON:TEP)
Smiths News logo with Communication Services background

Canaccord Genuity Group Reiterates Buy Rating for Smiths News (LON:SNWS)

LON:SNWS
Read Canaccord Genuity Group Reiterates Buy Rating for Smiths News (LON:SNWS)
Kodal Minerals logo with Basic Materials background

Kodal Minerals (LON:KOD) Receives Speculative Buy Rating from Canaccord Genuity Group

LON:KOD
Read Kodal Minerals (LON:KOD) Receives Speculative Buy Rating from Canaccord Genuity Group
Merck & Co., Inc. logo with Medical background

Merck & Co., Inc. (NYSE:MRK) Coverage Initiated at Citigroup

NYSE:MRK
Read Merck & Co., Inc. (NYSE:MRK) Coverage Initiated at Citigroup
Super Micro Computer logo with Computer and Technology background

Super Micro Computer (NASDAQ:SMCI) Raised to "Market Perform" at CJS Securities

NASDAQ:SMCI
Read Super Micro Computer (NASDAQ:SMCI) Raised to "Market Perform" at CJS Securities
Duke Energy logo with Utilities background

Duke Energy (NYSE:DUK) Price Target Raised to $139.00

NYSE:DUK
Read Duke Energy (NYSE:DUK) Price Target Raised to $139.00
Rhythm Pharmaceuticals logo with Medical background

Wells Fargo & Company Boosts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $144.00

NASDAQ:RYTM
Read Wells Fargo & Company Boosts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $144.00
BioNTech logo with Medical background

Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

NASDAQ:BNTX
Read Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00
EOG Resources logo with Energy background

EOG Resources (NYSE:EOG) Price Target Raised to $149.00 at Mizuho

NYSE:EOG
Read EOG Resources (NYSE:EOG) Price Target Raised to $149.00 at Mizuho
Travere Therapeutics logo with Medical background

Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

NASDAQ:TVTX
Read Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Embecta logo with Medical background

Mizuho Lowers Embecta (NASDAQ:EMBC) Price Target to $5.00

NASDAQ:EMBC
Read Mizuho Lowers Embecta (NASDAQ:EMBC) Price Target to $5.00
Jazz Pharmaceuticals logo with Medical background

Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $265.00 Price Target at Wells Fargo & Company

NASDAQ:JAZZ
Read Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $265.00 Price Target at Wells Fargo & Company
Hinge Health logo with Medical background

Hinge Health (NYSE:HNGE) Price Target Raised to $80.00 at Wells Fargo & Company

NYSE:HNGE
Read Hinge Health (NYSE:HNGE) Price Target Raised to $80.00 at Wells Fargo & Company
Integra LifeSciences logo with Medical background

Wells Fargo & Company Increases Integra LifeSciences (NASDAQ:IART) Price Target to $15.00

NASDAQ:IART
Read Wells Fargo & Company Increases Integra LifeSciences (NASDAQ:IART) Price Target to $15.00
Skyworks Solutions logo with Computer and Technology background

KeyCorp Raises Skyworks Solutions (NASDAQ:SWKS) Price Target to $85.00

NASDAQ:SWKS
Read KeyCorp Raises Skyworks Solutions (NASDAQ:SWKS) Price Target to $85.00
Solventum logo with Medical background

Solventum (NYSE:SOLV) Price Target Cut to $70.00 by Analysts at Wells Fargo & Company

NYSE:SOLV
Read Solventum (NYSE:SOLV) Price Target Cut to $70.00 by Analysts at Wells Fargo & Company
Alkermes logo with Medical background

Alkermes (NASDAQ:ALKS) Price Target Raised to $44.00 at Wells Fargo & Company

NASDAQ:ALKS
Read Alkermes (NASDAQ:ALKS) Price Target Raised to $44.00 at Wells Fargo & Company
Ultragenyx Pharmaceutical logo with Medical background

Wells Fargo & Company Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

NASDAQ:RARE
Read Wells Fargo & Company Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price
Myriad Genetics logo with Medical background

Myriad Genetics (NASDAQ:MYGN) Given New $5.50 Price Target at Wells Fargo & Company

NASDAQ:MYGN
Read Myriad Genetics (NASDAQ:MYGN) Given New $5.50 Price Target at Wells Fargo & Company
Fiserv logo with Business Services background

Mizuho Issues Pessimistic Forecast for Fiserv (NASDAQ:FISV) Stock Price

NASDAQ:FISV
Read Mizuho Issues Pessimistic Forecast for Fiserv (NASDAQ:FISV) Stock Price
Gulfport Energy logo with Energy background

Gulfport Energy (NYSE:GPOR) Price Target Raised to $251.00

NYSE:GPOR
Read Gulfport Energy (NYSE:GPOR) Price Target Raised to $251.00

Featured Articles and Offers

Alert Categories

All Alerts